Cargando…
Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients
The novel coronavirus infection has spread worldwide, causing a wide spectrum of clinical manifestations. Most patients develop moderate clinical illness, but a substantial number will experience severe pneumonia, which may rapidly progress to acute respiratory distress syndrome and multiple organ f...
Autores principales: | Chalkias, Athanasios, Mouzarou, Angeliki, Samara, Evangelia, Xanthos, Theodoros, Ischaki, Eleni, Pantazopoulos, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327460/ https://www.ncbi.nlm.nih.gov/pubmed/32613288 http://dx.doi.org/10.1007/s40291-020-00481-8 |
Ejemplares similares
-
A Critical Appraisal of the Effects of Anesthetics on Immune-system Modulation in Critically Ill Patients With COVID-19
por: Chalkias, Athanasios, et al.
Publicado: (2021) -
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
por: Luo, Shengyuan, et al.
Publicado: (2022) -
Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017) -
WITHDRAWN: Soluble urokinase plasminogen activator
receptor and its complicated role in hemodialysis (HD) patients with Covid-19
infection
por: Griveas, Ioannis, et al.
Publicado: (2022) -
Airway Pressure Monitoring May Improve Small Airway Flow, Hemodynamics, and Tissue Oxygenation
por: Chalkias, Athanasios, et al.
Publicado: (2019)